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Objective  To investigate changes in (1) the colonic response to acetylcholine (Ach), (2) the muscarinic (M) 
receptors in the colon, and (3) the levels of colonic contraction-related proteins after a spinal cord injury (SCI).
Method  We divided 16 Sprague-Dawley rats into 2 groups: the control group and the SCI group. A spinal cord 
transection was performed surgically at the T10 vertebral level. After 1 week, the entire colon was divided into 2 
segments, the proximal and distal colon. Each segment was mounted in a longitudinal or circular muscle direction   
in a 10-ml organ bath. We determined the intergroup differences as percentage changes in contractility after 
Ach treatment alone, Ach treatment with M2 receptor antagonist (AQ-RA741) pretreatment, and Ach treatment 
with M3 receptor antagonist (4-DAMP) pretreatment. Western blot analyses were performed to determine the 
expression level of RhoA, and heat shock protein 27 (HSP27).
Results  Compared to the control rats, the SCI rats showed an increased response to Ach along both the 
directions in the proximal colon (p<0.05). Compared to the control group, in the SCI group, the Ach response was 
signifi  cantly diff  erent in the proximal segment under AQ-RA741 pretreatment (p<0.05) and in the distal segment 
under 4-DAMP pretreatment (p<0.05). Findings of the western blot analyses showed a signifi  cant decrease in the 
level of protein gene product 9.5 in the proximal and distal colon and a signifi  cant increase in the level of RhoA 
and HSP27 in the proximal colon of the SCI rats.
Conclusion  Our results suggest that changes in colonic contractility after SCI are partly attributable to changes in 
the M receptor subtypes.
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INTRODUCTION
  Spinal cord injury (SCI) leads to the development of 
neurogenic bowel, which induces chronic constipation, 
fecal incontinence, and fecal impaction because of a 
change in large intestinal motility and the impairment 
of defecation control.
1 Although the mechanism of 
development of neurogenic bowel after SCI is not cle-
arly understood, Longo et al.
2 and Menardo et al.
3 have 
reported that in most SCI patients, colonic motility is 
decreased. Thus, the colonic transit time is prolonged, 
particularly in the descending and sigmoid colon. Th  ere-
fore, these authors suggested that the main me  chanism 
of development of constipation in the neurogenic bowel 
is the reduced motility of the distal large intestine. How-
ever, previous studies have shown that after SCI, the 
colonic transit time was prolonged mainly in the left co-
lon and rectum.
3 Also, the transit time in the right and 
left colon was comparable but that in the rectum and 
sigmoid colon was prolonged,
4 and the transmit time was 
not prolonged when the regions above the 9th thoracic 
vertebra were injured.
5
  The extrinsic innervation controls the motility of the 
large intestine via the autonomic nervous system, whe-
reas the intrinsic innervation, including the submucosal 
plexus and myenteric plexus, control the contraction or 
collaborative movements of the colonic smooth mu  scles.
2 
  The neurotransmitter acetylcholine (Ach) acts on the 
smooth muscle muscarinic (M) receptors and is a major 
determinant of colonic motility. Moreover, the M type 2 
(M2) and type 3 (M3) receptors, in particular, are present 
on intestinal smooth muscles  and they are the major 
excitatory neurotransmitters  that control the contraction 
of intestinal smooth muscles.
6
  Th   e M receptors consist of 5 subtypes (M1 to M5), and 
the M2 and M3 receptors are primarily involved in the 
motility of the gastrointestinal tract.
7 The M2 and M3 
mRNA and protein were detected in the gastrointestinal 
smooth muscles by performing northern blot analysis, 
reverse transcriptase polymerase chain reaction (RT-
PCR), and receptor immunoprecipitation.
7 In 1991, 
Zhang et al.
6 reported radioligand binding and northern 
blot analysis that showed 82% of the M receptors on 
canine colonic smooth muscles were M2, whereas 
18% were M3 receptors. Similarly, compared to the M3 
receptors, the M2 receptors were the primary and most 
abundant receptors in the smooth muscles of the bladder.   
Although the density of the M2 receptors is usually 
greater than that of the M3 receptors, smooth muscle 
contraction is mainly mediated by the M3 receptors.
7 
Under disease states, the number and sensitivity of the M 
receptors may be altered. For example, the number of M2 
receptors increased in the bladder of diabetic rats.
8 In rats 
with SCI, the increase in the density of all M receptors 
and the change in receptor subtype from M3 to M2 were 
thought to cause bladder hyperreflexia.
9 The findings 
of these previous reports suggest that SCI may cause a 
concomitant change in bowel function and the number 
or sensitivity of the M receptors on the colonic smooth 
muscles. However, only a few studies on the change of M 
receptor subtypes in colonic smooth muscles have been 
reported to date. 
  We hypothesized that the change in bowel movements 
after SCI may be associated with an altered Ach response 
due to the change in M2 or M3 receptors. Therefore, 
we performed an in vitro organ bath study by dividing 
the proximal and distal colon along a circular and 
longitudinal muscle direction in order to examine the 
changes in contractility of each colonic segment after 
an SCI, with or without M2 or M3 receptor antagonist 
pretreatment.
MATERIALS AND METHODS 
Experimental animals and SCI
  Animal experiments were performed in accordance to 
the Institutional Guidelines provided by the Committee 
on Animal Research at Wonkwang  University, and eff  orts 
were made to minimize both animal suffering and the 
number of animals. We purchased 16 female Sprague-
Dawley rats weighing 200–250 g from Samtaco (BioKorea, 
Osan, Korea), and these were divided into 2 groups: the 
group without surgical intervention (control group; n= 
8), and the group with SCI (SCI group; n=8). All surgical 
procedures including SCI were performed by the same 
investigator. All rats received intraperitoneal injections 
of 300 mg/kg chloral hydrate for induction of anesthesia. 
Complete spinal cord transection was performed at the 
T10 vetebral level, and Gelfoam
® (Baxter Healthcare 
Corp., Hayward, USA) was inserted into the lesion site 
to separate the spinal sections. After the completion of 
all surgical procedures, the surgical area was sterilized. Changes of Colonic Muscarinic Receptors in SCI Rats
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Gentamicin (100 mg/kg) was injected intramuscularly for 
3 days to prevent wound infection.
Recording of bowel movements 
  All rats were killed by cervical dislocation at day 7 
after the surgery, after which the abdominal cavity was 
immediately opened and the entire colon was resected. 
Some parts of the colonic tissues were frozen and stored 
im  mediately after resection for western blot  analysis. 
The remaining parts were immersed in an organ bath 
fi  lled with Kreb’s solution saturated with oxygen (95% O2, 
5% CO2) at 37
oC. The entire colon was divided into the 
proximal (within 4 cm from the end of cecum) and distal 
segment (within 4 cm from the anus). Each segment was 
cut into 1 cm pieces. One end of the tissue sections was 
fi  xed to the base of the organ bath, whereas the other end 
was connected to a force transducer (FT03; Grass, USA) 
either longitudinally or in a circular fashion by using 
cotton threads. Th   e preload tension was adjusted to ap-
proximately 1 g. The tissues were allowed to equilibrate 
for at least 60 min to obtain constant contractions. Spon-
taneous contractions were recorded. Thereafter, vari-
ous concentrations of Ach (10
−9 M to 10
−4 M) were 
ad  ded stepwise and the change in contractility  with 
Ach concentrations was recorded. In addition, tissues 
pretreated with the M2 or M3 receptor antagonists (10
−7 
M) were treated with stepwise increasing concentrations 
of Ach (10
−9 M to 10
−4 M), and the change in the con-
tractility with increasing Ach concentrations was re-
corded. All data were recorded using the PowerLab 
data acquisition system (AD Instruments, Sydney, 
Australia). From the recorded waveform, the area under 
the curve was calculated by integrating all the data, and 
the differences between the maximum and minimum 
values obtained immediately before and after the drug 
treatment were compared. Each test lasted for at least 5 
min. 
Drugs 
  Ach, the M2 receptor antagonist 11-[[4-[4-(die-
thylamino)butyl]-1-piperidinyl]acetyl]-5,11-dihydro-
6H-pyridol[2,3-b][1,4] benzodiazepin-6-one (AQ-
RA741) and the M3 receptor antagonist 1,1-dimethyl-4- 
diphenylacetoxypiperidinium iodide (4-DAMP) were 
purchased from Sigma South Croydon, Australia. Dif-
ferent concentrations of Ach (10
−9 M to 10
−4 M) and 10-7 
M of the antagonists  were added to the organ baths 
containing 10 ml Kreb’s solution.
Western blot analysis
  Th   e expression levels of protein gene product 9.5 (PGP 9.5), 
heat shock protein 27 (HSP 27), and RhoA were measured 
using western blot analysis. Colonic tissues  were washed 
with Tris buffered saline (TBS), and approximately 5 g 
tissue was added to lysis buffer (25 mM Tris-Cl, 1 mM 
ethylene glycol bis [β-aminoethyl ether]-N,N,N′,N′-tetra-
acetic acid, 1 mM dithiothreitol, 0.1% Triton X-100, 
protease inhibitor cocktail, and phosphatase inhibitor 
cocktail; pH 7.4) and homogenized. The samples were 
then centrifuged at 12,000 rpm for 30 min, and the 
cytosolic fraction was obtained. The protein con  cen-
tration was estimated using bovine serum albu  min 
(BSA) as a standard.  The protein concentration of all 
samples was adjusted in order to apply the same amount 
of protein. The sample buffer  was added to the sam-
ples, the mixture was boiled at 100
oC for 5 min, and elec-
tro  phoresis was performed at 100 V for 2 h by using a 
minigel electrophoresis apparatus (mini-PROTEIN Tetra 
cell; Bio-Rad Laboratories, Inc., Hercules, CA). After 
electrophoresis, the gels were stained with Coomassie 
brilliant blue R-250 for 1 h. Following that, the samples 
were destained with 10% acetic acid and 10% methanol, 
and the protein bands were observed. Th   e proteins were 
transferred to 0.45 μm polyvinylidene difl  uoride (PVDF) 
membranes (Roche Diagnostics GmbH, Mannheim, 
Germany) using protein transfer apparatus (mini Trans-
blot cell; Bio-Rad Laboratories) at 100 V for 90 min. To 
prevent non-specific binding of the primary antibody, 
the PVDF membranes were incubated with blocking 
buff  er (5% skim milk in 0.05% tween 20–Tris buff  er saline 
[TBST, pH 7.6]) for 1 h. The membranes were washed 3 
times with TBST and incubated overnight at 4°C with 
primary antibodies (PGP 9.5, HSP 27, and RhoA) that 
were diluted to 1:1,000 with TBS containing 3% BSA. Th  e 
membranes were then washed 4 times with TBST. Next, 
the membranes were incubated for 1 h with a horseradish 
peroxidase (HRP)-conjugated goat anti-rabbit IgG 
secondary antibody (Enzo Life Science International Inc., 
Plymouth Meeting, PA) (1:5,000). The membranes were 
washed 4 times with TBST, incubated with Immobilon 
Western chemiluminescent HRP substrate (Millipore., 
MA, USA), and exposed to a chemiluminescence fi  lm in Min Cheol Joo, et al.
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the dark room. Th   e expression levels of PGP 9.5, HSP27, 
and RhoA were compared. In addition, as a control ex-
peri  ment, double staining for glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) was performed with PGP 
9.5, HSP27, and RhoA under the same conditions.
Data analysis 
  Data analysis was conducted using the Statistical Package 
for the Social Sciences v 11.0 (SPSS Inc., Chicago, USA). 
Dif  ferences in the contractility  of tissues treated with 
different compounds were determined for the control 
and SCI groups by performing the independent t-test. We 
considered p-values less than 0.05 as statistically signi-
fi  cant. 
RESULTS 
Macroscopic ﬁ  ndings of the large intestine
  Fecal impaction in the large intestines of the SCI rats 
was more than that in the large intestines of the control 
rats, and distended large intestines were observed in 
the SCI rats. Fecal impaction was more noticeable in the 
distal colon. In addition, fecal pellets of the SCI rats were 
darker and harder than those of the controls rats (Fig. 1). 
Eﬀ  ects of Ach on spontaneous contractions
  In the organ bath experiment, the contractility of both 
the proximal and distal colon increased with increasing 
concentration of Ach in both control and SCI groups. 
How  ever, the contractility in the proximal colon after 
Ach treatment in the SCI group was significantly higher 
than that in the control group (p<0.05). The intergroup 
difference for contractility in the distal colon was not 
signifi  cant (Fig. 2). 
Response to Ach after pretreatment with AQ-RA741 or 
4-DAMP 
  Pretreatment with AQ-RA741, which primarily blocks 
the M2 receptors, reduced the response to Ach in both 
the proximal and distal colon of rats belonging to both 
the groups. Similar to the results obtained for Ach 
treat  ment without any pretreatment, after AQ-RA741 
pretreatment, Ach-induced contraction showed a signi-
fi  cant increase in the proximal colon of the SCI rats than 
in the proximal colon of the control rats (Fig. 3, p<0.05). 
In contrast, after pretreatment with 4-DAMP, which pri-
marily blocks the M3 receptors, the response to Ach in 
both proximal and distal colon was signifi  cantly reduced. 
In addition, treatment of the colon specimens, except the 
longitudinal muscle direction in the proximal colon, with 
high concentration Ach (>10
−5 M) did not produce any 
differences in Ach-induced contraction in the proximal 
and the distal colon (Fig. 4, p < 0.05). 
Western blot analysis 
  Th   e results of the western blot analysis showed that the 
Fig. 1. Photographs of the colon of 
rats belonging to both groups. The 
upper and lower panels show the 
colons of the control (CON) spinal 
cord injured (SCI) rats, respectively. 
Note the fecal impaction in the distal 
colon of the SCI rats.Changes of Colonic Muscarinic Receptors in SCI Rats
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expression of RhoA and HSP27 in the distal colon was 
higher than that observed in the proximal colon in both 
groups. Th   e expression of these proteins in the proximal 
colon of the SCI rats was signifi  cantly higher than that in 
the proximal colon of the control rats (Fig. 5-A, C, and 
D, p<0.05). In contrast, the expression of PGP 9.5 in the 
proximal and distal colon of the SCI rats was signifi  cantly 
lower than that in the proximal and distal colon of the 
control rats (Fig. 5-A and B, p<0.05). 
DISCUSSION
  Reasons for diffi   culty with defecation after SCI have not 
yet been elucidated. To date, several mechanisms such as 
somatic and visceral sensory impairment due to neural 
injury, dysfunction of bowel movement control, and 
loss of voluntary control of the anal sphincter have been 
suggested to explain this phenomenon. Meshkinpour 
et al.
10 reported a markedly reduced motility index in 
the distal colon after SCI. Fajardo et al.
11 have reported 
that the baseline colonic activity significantly reduced 
after SCI, and they suggested that this alteration may 
be associated with the difficulty with evacuation. Al-
though the colonic transit time after SCI was known to 
be prolonged primarily in the distal colon, the transit 
time in each colonic segment is still debatable. Such 
diff  erences in the previously reported results have been 
attributed to the diff  erences between animal models and 
humans,
3,10 between complete and incomplete injury,
7 
and in neurological injury levels.
12 Th   erefore, in order to 
identify whether colonic motility in the different colo-
nic segments is different, we examined the change in 
con  tractility in response to Ach with and without M2 or 
M3 receptor antagonist pretreatment at 1 week after the 
Fig. 2. Percentage changes in contractility after treatment with acetylcholine (Ach) for the control (CON) and spinal cord injury 
(SCI) groups. Th   e intergroup diff  erence in the percentage changes in contractility in the proximal colon along the longitudinal 
and circular muscle direction was signifi  cant. Th   e values are expressed as mean±SD. *Denotes signifi  cant diff  erence between 
the CON and SCI groups (*p<0.05). Min Cheol Joo, et al.
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SCI. Our results showed that compared with the con-
trol rats, the SCI rats exhibited a significant increase of 
contractility in the proximal colon. Compared with the 
control rats, the SCI rats showed a decreased contractility 
in the distal colon, but the decrease was not statistically 
signifi  cant.
  The overall response to Ach in the tissues pretreated 
with AQ-RA741 was lower than the response observed 
in tissues not pretreated with AQ-RA741. Furthermore, 
compared to the control rats, the SCI rats showed a 
signi  ficant increase in contractility only in the proximal 
colon. In contrast, pretreatment with 4-DAMP resulted 
in a marked reduction in contractility after Ach treat-
ment, and the intergroup difference in contractility 
of the proximal colon was not significant. Although 
after treatment with high concentrations of Ach, the 
contractility along the longitudinal muscle direction 
of the distal colon was reduced in both the groups, the 
reduction was significant only for the SCI group. These 
results indicate that compared to the distal colon, the 
proximal colon is more responsive to Ach after SCI.
  To summarize, the experiments involving the use of 
receptor antagonists show that the intergroup diff  erence 
in the response of the proximal colon to Ach was signi-
ficantly different when tissues were pretreated with 
an M2 antagonist, whereas the intergroup differences 
in the response of the proximal colon to Ach was not 
signifi  cantly diff  erent, but the contractility in all muscle 
directions  was reduced when the tissues were pretreated 
with an M3 antagonist. These results suggest that the 
change in Ach responsive after an SCI is due to the 
increase either in the response of M3 or in the number of 
receptors in the proximal colon. 
  Results of previous studies show that only M2 and M3 
receptors are expressed in the colon of animals as well as 
of humans. In humans, the ratio of M2 and M3 receptors 
Fig. 3. Percentage changes in contractility of the proximal and distal colon of the control (CON) and spinal cord injury (SCI) 
groups after acetylcholine (Ach) treatment of samples pretreated with AQ-RA741. Th   e intergroup diff  erence in the percentage 
changes in contractility in the proximal colon along the longitudinal and circular muscle direction was signifi  cant. Th  e  values 
are expressed as mean±SD. *Denotes signifi  cant diff  erence between the CON and SCI groups (*p<0.05). Changes of Colonic Muscarinic Receptors in SCI Rats
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in the colon is 4 : 1 and a similar ratio is seen in the 
blad der.
13,14 The role of each receptor in humans is still 
debatable. However, M3 receptors are reported to play 
a major role in the bowel movements in animals, and 
the colonic transit time decreases if these receptors are 
blocked.
15 Similarly, these receptors play a major role in 
the bladder and the colon. Recently, the importance of 
the role of M2 receptor, particularly in the colon, where 
their contribution is more than that in the bladder, has 
been emphasized.
16 After M3 antagonist pretreatment, 
the contractility along the longitudinal muscle direction 
in the distal colon reduced for both the groups, but the 
reduction was significant only for the SCI group. This 
result suggests that the major change in the distal colon 
may be the reduced response of the M2 receptors rather 
than that of the M3 receptors.
  Taken together, our results show that after SCI, the in-
creased contractility along both longitudinal and cir-
cular muscle directions in the proximal colon may be 
attributable to the increased response of the M3 recep-
tors, whereas the reduced contractility in the distal colon 
may be attributable to the reduced response of the M2 
receptors. In other words, SCI may lead to alterations 
in the number or activity of the M receptors in colonic 
smooth muscles, and this may change colonic motility. 
Th   erefore, to understand the mechanism of the alteration 
of colonic motility after an SCI, studies should investigate 
the changes in coordinated muscle movements and in 
inhibitory systems involving nitric oxide in addition to 
changes in M receptors.
  HSP27, along with caldesmon, is associated with bo  wel 
contractility after an SCI and is involved in the open  ing 
and closing of the active sites where the myosin heads 
are attached during smooth muscle contraction. Previous 
studies have shown that p38 mitogen-activated protein 
(MAP) kinases induce phosphorylation of HSP27,
17,18 and 
Fig. 4. Percentage changes in contractility of the proximal and distal colon of the CON and SCI groups after Ach treatment 
of samples pretreated with 4-DAMP. Th   e intergroup diff  erence in the percentage changes in contractility in the distal colon 
along the longitudinal muscle direction was signifi  cant. Th   e values are expressed as mean±SD. *Denotes signifi  cant diff  erence 
between the CON and SCI groups (*p<0.05). Min Cheol Joo, et al.
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the increase in phosphorylated HSP27 is associated with 
the increase in contractility of the corresponding smooth 
muscles.
19 In contrast, smooth muscle contraction is ini-
tiated by the phosphorylation of myosin light chain (MLC) 
and controlled by MLC kinase (MLCK), which is activated 
by the calcium–calmodulin complex. MLC phosphatase 
(MLCP) antagonizes MLCK, and MLCP levels are re-
duced by RhoA, protein kinase C, and smooth muscle 
phosphoprotein CPI-17.
20 RhoA not only suppresses 
MLCP activity, but also colocalizes with the actin binding 
protein HSP27, and thus, is involved in contractility. In 
addition, RhoA plays a decisive role in Ca
2+ sensitization. 
Through this mechanism, it maintains phosphorylated 
myosin and induces repeated and continuous smooth 
muscle contraction.
20 Th   erefore, during an Ach response, 
both HSP27 and RhoA are associated with the increase 
and decrease in contractility of smooth muscles, and an 
increase in the level of these proteins plays an important 
role in the induction and maintenance of smooth muscle 
contraction.
20 Our results showed a significant increase 
in the levels of HSP27 and RhoA in the proximal colon of 
the SCI rats than in the proximal colon of the control rats. 
Th  is  fi  nding is in agreement with results of the organ bath 
study that showed a significant intergroup difference in 
the Ach response of the proximal segment of the colon. 
  PGP 9.5 is a well-known general neuronal marker and 
specifi  cally reacts with neurons and the neuroendocrine 
system.
21 Recent studies have shown that PGP 9.5-postive 
immunoreactive cells are widely distributed throughout 
the lower gastrointestinal tract, and their density in the 
rectum, and the distal, transverse, and proximal colon is 
not diff  erent.
22 A previous study showed that PGP 9.5 level 
was elevated in an overactive bladder that developed 
after SCI.
23 However, studies on modulation of PGP 9.5 
Fig. 5. Results of western blot analysis for PGP 9.5 (B), RhoA (C), and HSP 27 (D) in the proximal and distal colon. (A) shows 
representative cases of each protein. Th   e intergroup diff  erences in the levels of PGP 9.5 in the proximal and distal colon and of 
RhoA and HSP 27 in the proximal colon were signifi  cant. Th   e values are as expressed mean±SD. *Denotes signifi  cant diff  erence 
between the CON and SCI groups (*p < 0.05).Changes of Colonic Muscarinic Receptors in SCI Rats
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level in the colon have been rarely reported. Although we 
observed an increase in the levels of proteins associated 
with contractility in the proximal colon, the PGP 9.5 level, 
which reflects the increase or decrease of innervation, 
was significantly decreased in both the proximal and 
distal colon. This finding is consistent with that of pre-
vious studies showing reduced PGP 9.5 levels in the 
peripheral tissues after nerve injuries,
24 and this may be 
because of the blockage of neurotransmission from the 
regions anterior to the SCI. 
CONCLUSION
  After Ach treatment, the contractility along both the lon-
gitudinal and circular muscle directions in the proximal 
colon of the SCI rats was significantly higher than that 
in the proximal colon of the control rats. When Ach 
treatment was conducted after AQ-RA741 pretreatment, 
the contractility along the longitudinal and circular 
muscle direction in the proximal colon of the SCI rats 
showed a significant increase. When Ach treatment 
was conducted after 4-DAMP pretreatment, only the 
contractility along the longitudinal muscle direction 
in the distal colon of the control rats significantly in-
creased. Furthermore, the levels of the contraction-
asso  ciated proteins in the proximal colon increased, and 
the alterations in colonic motility were associated with 
changes in the M receptor subtypes. Such alterations 
were associated with the increase of contractility in the 
proximal colon rather than in the distal colon. Moreover, 
we believe that the decrease in the Ach response of the 
distal colon partially contributed to the reduced con-
tractility. To understand the mechanism of reduced 
contractility in the distal colon, additional studies should 
be conducted on the modulation of proteins associated 
with contraction or alteration of excitatory or inhibitory 
neurotransmitters or receptors that are associated with 
bowel contractility.
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